Type II diabetes treatment and risk of dementia

Buchmann N, Fink A, Tegeler C, Demuth I, Doblhammer G, Steinhagen-Thiessen E (2019) Different treatment forms of type II diabetes and the risk of dementia in German health claims data. Acta Diabetol. https://doi.org/10.1007/s00592-019-01332-7 McIntosh EC, Nation DA, Alzheimer’ s Disease Neuroimaging Initiative (2019) Importance of treatment status in links between type 2 diabetes and Alzheimer’s disease. Diabetes Care 42:972–979 Cao B, Rosenblat JD, Brietzke E et al (2018) Comparative efficacy and acceptability of antidiabetic agents for Alzheimer’s disease and mild cognitive impairment: a systematic review and network meta-analysis. Diabetes Obes Metab 20:2467–2471 Avgerinos KI, Kalaitzidis G, Malli A, Kalaitzoglou D, Myserlis PG, Lioutas VA (2018) Intranasal insulin in Alzheimer’s dementia or mild cognitive impairment: a systematic review. J Neurol 265:1497–1510 Claxton A, Baker LD, Wilkinson CW et al (2013) Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer’s disease. J Alzheimers Dis 35:789–797